115 related articles for article (PubMed ID: 9228925)
1. Constant delivery of proinsulin by encapsulation of transfected cells.
Taniguchi H; Fukao K; Nakauchi H
J Surg Res; 1997 Jun; 70(1):41-5. PubMed ID: 9228925
[TBL] [Abstract][Full Text] [Related]
2. Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells.
Kawakami Y; Yamaoka T; Hirochika R; Yamashita K; Itakura M; Nakauchi H
Diabetes; 1992 Aug; 41(8):956-61. PubMed ID: 1628770
[TBL] [Abstract][Full Text] [Related]
3. Control of proinsulin production by sense-anti-sense regulation in response to glucocorticoids.
Taniguchi K; Hirochika R; Fukao K; Nakauchi H
Cell Transplant; 1996; 5(5 Suppl 1):S55-7. PubMed ID: 8889233
[TBL] [Abstract][Full Text] [Related]
4. Construction of human insulin gene expression recombinant and its effect on blood glucose of diabetic rats.
Wang H; Xiao X; Fang F; Sun Q
Chin Med J (Engl); 1998 Oct; 111(10):899-902. PubMed ID: 11189235
[TBL] [Abstract][Full Text] [Related]
5. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
Lee RH; Roll G; Nguyen V; Willenbring H; Tang Q; Kang SM; Stock PG
Transplant Proc; 2014; 46(6):2002-6. PubMed ID: 25131094
[TBL] [Abstract][Full Text] [Related]
6. Treatment of diabetic mice with encapsulated fibroblasts producing human proinsulin.
Taniguchi H; Nakauchi H; Iwata H; Amemiya H; Fukao K
Transplant Proc; 1992 Dec; 24(6):2977-8. PubMed ID: 1466020
[No Abstract] [Full Text] [Related]
7. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.
Yin D; Tang JG
FEBS Lett; 2001 Apr; 495(1-2):16-20. PubMed ID: 11322940
[TBL] [Abstract][Full Text] [Related]
8. Insulin delivery with plasmid DNA.
Abai AM; Hobart PM; Barnhart KM
Hum Gene Ther; 1999 Nov; 10(16):2637-49. PubMed ID: 10566891
[TBL] [Abstract][Full Text] [Related]
9. Loss of ganciclovir sensitivity by exclusion of thymidine kinase gene from transplanted proinsulin-producing fibroblasts as a gene therapy model for diabetes.
Yoshimoto K; Murakami R; Moritani M; Ohta M; Iwahana H; Nakauchi H; Itakura M
Gene Ther; 1996 Mar; 3(3):230-4. PubMed ID: 8646554
[TBL] [Abstract][Full Text] [Related]
10. [Recombination of RegIII-proinsulin-pBudCE4.1 plasmid and its therapeutic effect on STZ-induced type 1 diabetes mellitus].
Hou WR; Xie SN; Lu JL; Xi W; Luo X; Xiang M
Yao Xue Xue Bao; 2010 Aug; 45(8):987-94. PubMed ID: 21351584
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice.
Short DK; Okada S; Yamauchi K; Pessin JE
Am J Physiol; 1998 Nov; 275(5):E748-56. PubMed ID: 9814992
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
Croze F; Prud'homme GJ
J Gene Med; 2003 May; 5(5):425-37. PubMed ID: 12731091
[TBL] [Abstract][Full Text] [Related]
13. Insulin delivery by somatic cell gene therapy.
Stewart C; Taylor NA; Docherty K; Bailey CJ
J Mol Endocrinol; 1993 Dec; 11(3):335-41. PubMed ID: 8148041
[TBL] [Abstract][Full Text] [Related]
14. Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.
Chen YS; Zaro JL; Zhang D; Huang N; Simon A; Shen WC
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373562
[TBL] [Abstract][Full Text] [Related]
15. Reversal of diabetes in mice by implantation of human fibroblasts genetically engineered to release mature human insulin.
Falqui L; Martinenghi S; Severini GM; Corbella P; Taglietti MV; Arcelloni C; Sarugeri E; Monti LD; Paroni R; Dozio N; Pozza G; Bordignon C
Hum Gene Ther; 1999 Jul; 10(11):1753-62. PubMed ID: 10446915
[TBL] [Abstract][Full Text] [Related]
16. Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice.
Kaur G; Thompson LA; Babcock RL; Mueller K; Dufour JM
DNA Cell Biol; 2018 Aug; 37(8):680-690. PubMed ID: 29927618
[TBL] [Abstract][Full Text] [Related]
17. Reversal of hyperglycemia in diabetic NOD mice by human proinsulin gene therapy.
Kasten-Jolly J; Aubrey MT; Conti DJ; Rosano TG; Ross JS; Freed BM
Transplant Proc; 1997 Jun; 29(4):2216-8. PubMed ID: 9193599
[No Abstract] [Full Text] [Related]
18. Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene.
Bochan MR; Shah R; Sidner RA; Jindal RM
Transplant Proc; 1999; 31(1-2):690-1. PubMed ID: 10083298
[No Abstract] [Full Text] [Related]
19. Prospects for insulin delivery by ex-vivo somatic cell gene therapy.
Bailey CJ; Davies EL; Docherty K
J Mol Med (Berl); 1999 Jan; 77(1):244-9. PubMed ID: 9930972
[TBL] [Abstract][Full Text] [Related]
20. Glucose-dependent insulin release from genetically engineered K cells.
Cheung AT; Dayanandan B; Lewis JT; Korbutt GS; Rajotte RV; Bryer-Ash M; Boylan MO; Wolfe MM; Kieffer TJ
Science; 2000 Dec; 290(5498):1959-62. PubMed ID: 11110661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
